Monitoring anticoagulation in atrial fibrillation

Journal of Thrombosis and Thrombolysis

Volumn 21, Issue 2, 2006, Pages 191-198

  Sarawate, Chaitanya ^a   Sikirica, Mirko V ^a   Willey, Vincent J ^a   Bullano, Michael F ^a   Hauch, Ole ^b  

^a HEALTHCORE INC   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Administrative claims; Atrial fibrillation; Monitoring; Retrospective

Indexed keywords

WARFARIN;

AGED; ARTICLE; BLEEDING DISORDER; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; WARFARIN;

EID: 33645874183     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-4968-z     Document Type: Article

References (29)

1. American Heart Association (2004) Heart Disease and Stroke Statistics - 2004 Update. AHA 2-50
2. Singer DE, Albers GW, Dalen JE, et al. (2004) Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:429S-456S
3. Diringer MN, Edwards DF, Mattson DT, et al. (1999) Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 30:724-728
4. (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 323:1505-1511
5. (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 342:1255-1262
6. (1996) Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 348:633-638
7. Ezekowitz MD, Bridgers SL, James KE, et al. (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 327:1406-1412
8. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S (2004) Hemorrhagic complications of anticoagulant treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:287S-310S
9. Matchar DB (2003) Do anticoagulation management services improve care? Implications of the Managing Anticoagulation Services Trial. Card Electrophysiol Rev 7:379-381
10. Aronow WS, Ahn C, Kronzon I, Gutstein H (1999) Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin. J Am Geriatr Soc 47:366-368
11. Caro JJ, Flegel KM, Orejuela ME, et al. (1999) Anticoagulant prophylaxis against stroke in atrial fibrillation: Effectiveness in actual practice. CMAJ 161:493-497
12. Evans A, Perez I, Yu G, Kalra L (2001) Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation? Stroke 32:2828-2832
13. Evans A, Kalra L (2001) Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? Arch Intern Med 161:1443-1447
14. Gage BF, Boechler M, Doggette AL, et al. (2000) Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke 31:822-827
15. Go AS (2004) Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: Translating trials into clinical practice. Am J Manag Care 10:S58-S65
16. Kalra L, Yu G, Perez I, Lakhani A, Donaldson N (2000) Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ 320:1236-1239
17. Samsa GP, Matchar DB, Goldstein LB, et al. (2000) Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med 160:967-973
18. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236-239
19. Gage BF, Waterman AD, Shannon W, et al. (2001) Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 285:2864-2870
20. Bushnell CD, Matchar DB (2004) Pharmacoeconomics of atrial fibrillation and stroke prevention. Am J Manag Care 10:S66-S71
21. Ansell J, Hirsh J, Poller L, et al. (2004) The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:204S-233S
22. Casey M, Hanley K (2001) A measurement of the efficacy of anticoagulation monitoring in a general practice based setting. Ir Med J 94:245-246
23. Willey VJ, Bullano MF, Hauch O, et al. (2004) Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting. Clin Ther 26:1149-1159 1149-1159
24. (1991) Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation study: Final results. Circulation 84:527-539
25. Hylek EM, Go AS, Chang Y, et al. (2003) Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation. NEngl J Med 349:1019-1026
26. (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449-1457
27. Go AS, Hylek EM, Chang Y, et al. (2003) Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice? JAMA 290:2685-2692
28. Matchar DB, Samsa GP, Cohen SJ, Oddone EZ, Jurgelski AE (2002) Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: Results of the managing anticoagulation services trial. Am J Med 113:42-51
29. Armstrong EP, Manuchehri F (1997) Ambulatory care databases for managed care organizations. Am J Health Syst Pharm 54:1973-1983